U.S. Airlines Stock News

NYSE:CQP
NYSE:CQPOil and Gas

Should Stronger Q2 2026 Earnings and Profitability Trends at Cheniere (CQP) Require Action From Investors?

In August 2026, Cheniere Energy Partners, L.P. reported past second-quarter 2026 results showing revenue of US$2,583 million and net income of US$1,161 million, with basic earnings per share from continuing operations of US$2.14, all higher than the same period a year earlier. For the first half of 2026, the partnership’s revenue rose to US$6,183 million and net income to US$1,347 million, indicating stronger profitability and higher earnings per unit compared with the prior-year...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Marvell Stock And 2 AI Chip Plays Facing A Valuation Reset

AI related stocks have surged into the spotlight again after the ECB warned that the current rally in US tech valuations is edging into territory linked with past bubbles. That creates both risk and opportunity for anyone with exposure to AI heavy benchmarks. This article walks through 3 large cap AI and semiconductor leaders from our screener that could be especially sensitive if a sharp AI revaluation occurs. The stocks covered below are just a starting sample from this theme. The full...
NYSE:CRGY
NYSE:CRGYOil and Gas

Should Crescent’s Higher 2026 Output Targets and Steady Dividend Policy Require Action From CRGY Investors?

Crescent Energy recently raised its full-year 2026 production guidance, now targeting 327,000 to 335,000 barrels of oil equivalent per day, and confirmed a total quarterly dividend of US$0.12 per share with an ex-dividend date of August 17, 2026. This combination of higher expected output and a sustained dividend policy sharpens the focus on how Crescent balances growth with long-term payout support. We will now examine how the upgraded production guidance reshapes Crescent Energy’s...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Revolution Medicines (RVMD) Fully Valued After Its BeOne Collaboration Deal?

Revolution Medicines (RVMD) drew investor attention after announcing a multi part collaboration with BeOne Medicines. The deal covers joint clinical studies on RAS(ON) inhibitors and grants BeOne exclusive development and commercialization rights in select Asian markets. See our latest analysis for Revolution Medicines. The BeOne Medicines news lands at a time when Revolution Medicines has already seen strong share price momentum, including a 13.88% 1 month share price return and a year to...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Does Halozyme’s Raised 2026 Revenue Outlook And Aggressive Buybacks Change The Bull Case For HALO?

In August 2026, Halozyme Therapeutics reported past second-quarter 2026 results showing revenue of US$481.00 million and net income of US$229.91 million, alongside higher earnings per share and the completion of share repurchases totaling 13,452,356 shares for US$750.00 million across two programs. The company also raised its 2026 total revenue guidance to a range of US$1.84 billion to US$1.91 billion, indicating management’s increased confidence after strong first-half performance and...
NYSE:QTWO
NYSE:QTWOSoftware

How Investors Are Reacting To Q2 Holdings (QTWO) Slower Billings Growth And Rising Servicing Costs

Recently, analysis of Q2 Holdings highlighted that its cloud-based digital banking platform is now facing slower average billings growth alongside elevated servicing costs. This shift, occurring despite the company remaining profitable, raises fresh questions about how efficiently Q2 can scale its business model over time. We’ll now examine how concerns over slowing billings growth could reshape Q2 Holdings’ broader investment narrative for investors. Find 53 companies with promising cash...
NYSE:AIN
NYSE:AINMachinery

Stronger Q2 Results and Buybacks Might Change The Case For Investing In Albany International (AIN)

Albany International Corp. recently reported past second-quarter 2026 results showing higher sales of US$329.48 million and net income of US$17.41 million, alongside completing a US$173.36 million share repurchase program that retired 2,682,859 shares. The company also issued third-quarter 2026 revenue guidance of US$320 million to US$330 million, giving investors a clearer view of near-term operating momentum and capacity to generate earnings from continuing operations. With this...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Willdan Group (WLDN) Following Q2 Results And 2026 Targets Has An Undervalued Narrative

Willdan Group (WLDN) stock is in focus after the company reported second quarter 2026 results alongside full year revenue targets. Investors are assessing what the updated figures mean for the business. See our latest analysis for Willdan Group. At a share price of $83.47, Willdan Group has seen its share price return rise about 15% over the past month but decline around 22% year to date, while three year total shareholder return is above 2.5x. This suggests recent momentum is building again...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

Will GigaCloud’s (GCT) New Buyback, Guidance and M&A Plans Reshape Its Capital Allocation Narrative?

In early August 2026, GigaCloud Technology Inc. reported second-quarter 2026 results with higher revenue and net income year over year, issued third-quarter revenue guidance of US$375 million to US$400 million, extended its share repurchase plans, and signalled interest in further acquisitions once its New Classic integration progresses. Together, these earnings, buyback, and M&A updates highlight GigaCloud’s focus on scaling its B2B e-commerce platform while actively returning capital to...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Data Center Power Stocks Retail Investors Are Watching As AI Energy Demand Grows

Coordinated policy moves to support growth, curb inflation, and secure energy supplies have pushed data-center power and cooling from a back-room utility to a front-page investment story. When governments focus on electrification and resilient infrastructure, capital often follows. This article examines what that could mean for data-center infrastructure stocks that are influenced by these policy trends and highlights 3 companies from our screener that may be positioned to benefit. The three...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

Is APA’s Higher 2026 Output Guidance Altering The Investment Case For APA (APA)?

APA Corporation recently reported its second-quarter 2026 results, showing lower year-on-year production and revenue but higher net income of US$747 million and earnings per share of US$2.11. Shortly after, the company raised its 2026 full-year oil production guidance to 123,000 barrels per day from 120,000, underscoring management’s confidence in its operating plans despite softer recent volumes. Now we’ll consider how the higher 2026 oil production guidance could reshape APA’s previously...
NYSE:MPT
NYSE:MPTHealth Care REITs

The Bull Case For Medical Properties Trust (MPT) Could Change Following Near Breakeven Q2 Results And Maintained Dividend

In August 2026, Medical Properties Trust reported second-quarter results showing revenue of US$259.28 million and a much smaller net loss of US$2.6 million, alongside a Board-approved regular quarterly dividend of US$0.09 per share to be paid in October. The sharp year-on-year improvement from a US$98.36 million net loss to near break-even, and a swing to US$30.23 million net income for the first half, highlights how recent operational and financial adjustments are feeding into the REIT’s...
NasdaqGS:MPAA
NasdaqGS:MPAAAuto Components

Auto Parts Stocks For Investors Seeking Shelter From US Canada Tariff Risk

With the U.S. threatening tariffs of up to 50% on a wide range of Canadian exports and auto makers already warning that current trade frictions sit above typical 6% margins, investors are watching auto parts stocks closely. Rapid shifts in cross border costs can reshuffle which companies bear the strain and which are relatively shielded. This article looks at three U.S. listed auto parts stocks that are more directly exposed to this trade story. The stocks highlighted below are just a sample...
NYSE:BA
NYSE:BAAerospace & Defense

Did FAA Approval of the 737-7 Just Shift Boeing's (BA) Backlog Conversion Outlook?

In early August 2026, Boeing received an amended type certificate from the U.S. Federal Aviation Administration for its new 737-7 aircraft, clearing the smallest and longest-range member of the 737 MAX family for commercial service after a multi-year testing and safety review program. This certification not only enables deliveries to launch customer Southwest Airlines, but also reflects Boeing’s efforts to align more closely with evolving regulatory expectations on safety, human factors, and...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Dropbox (DBX) Moved Again, What Is The Market Watching Now?

Dropbox (DBX) has given investors fresh information to work with after raising its full year 2026 revenue guidance and laying out a new third quarter forecast that points to relatively flat underlying growth. See our latest analysis for Dropbox. Dropbox shares closed at US$33.38, with the stock giving back some ground in the last week after a 7-day share price decline of 3.5%. However, it is still showing stronger momentum with a 30-day share price return of 9.01% and a 90-day share price...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

Will Stronger Earnings, Tighter Guidance and a Higher Dividend Change Perdoceo Education's (PRDO) Narrative

In early August 2026, Perdoceo Education reported higher second‑quarter and first‑half revenue and net income, raised its earnings guidance, and announced a quarterly dividend increase to US$0.17 per share. Together, the stronger earnings, tighter earnings-per-share guidance range, and higher dividend point to management’s confidence in the company’s current operating trajectory and cash generation. With that in mind, we’ll now examine how the upbeat earnings guidance and dividend increase...
NYSE:KNF
NYSE:KNFBasic Materials

Knife River (KNF) Just Gave Investors Something To Think About

Knife River (KNF) drew fresh attention after releasing second quarter 2026 results that combined higher revenue with weaker profitability, while also lifting full year revenue guidance to a range of US$3.4b to US$3.6b. See our latest analysis for Knife River. Knife River’s share price has retreated recently, with a 1 month share price return of down 18.4% and a year to date share price return of down 8.4%. The 3 year total shareholder return of 34.1% still points to earlier strength, so...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

Stronger Profitability And Raised 2026 Outlook Could Be A Game Changer For Global-E Online (GLBE)

In August 2026, Global-E Online reported second-quarter 2026 results showing sales of US$299 million and net income of US$47.72 million, alongside sharply higher earnings per share versus a year earlier. Alongside this profitability improvement, the company raised its full-year 2026 revenue outlook to a range of US$1.31 billion to US$1.36 billion and issued new third-quarter guidance, highlighting confidence in its cross-border e-commerce model. We’ll now examine how Global-E’s stronger...
NYSE:DNOW
NYSE:DNOWTrade Distributors

Should DNOW’s (DNOW) Loss-Making Quarter and Merger Lawsuit Require Action From Investors?

DNOW Inc. reported past second-quarter 2026 results showing sales of US$1,307 million but a net loss of US$21 million, and completed a share repurchase program totaling 8,522,861 shares for US$112.21 million announced in January 2025. At the same time, a newly filed class action lawsuit alleging misleading disclosures around DNOW’s merger with MRC Global Inc. adds legal and integration uncertainty to an already loss-making period. Next, we’ll examine how the merger-related class action...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right?

Nurix Therapeutics (NRIX) has drawn investor attention after two key events. The company reported a new Phase 3 trial for its BTK degrader bexobrutideg and a separate US$10 million milestone payment from collaborator Sanofi. See our latest analysis for Nurix Therapeutics. Against this backdrop, Nurix Therapeutics’ recent clinical milestones and collaboration progress have coincided with strong momentum, with a 30 day share price return of 17.52% and a 1 year total shareholder return of...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Guidewire Stock And Other Software Names Built For Lower Rate Expectations

With inflation cooling and rate hike odds easing, investors are suddenly weighing a different set of risks and opportunities. Lower near term pressure from the Fed can support growth and quality stocks, even as a softer labor market and higher real yields keep recession worries alive. This article walks through three large cap U.S. stocks exposed to these cross currents and explains how this backdrop could help or hurt each one. The three stocks highlighted below are just a sample from this...
NYSE:ARE
NYSE:AREHealth Care REITs

Higher Treasury Yields Are Reshaping These US High Dividend Value Stocks

With the 30 year US Treasury yield touching 5.29% for the first time since 2007, long term money suddenly feels expensive and that reshapes how investors think about value, income and risk. Higher discount rates can pressure many stocks, yet they can also highlight companies that some investors see as better compensated for that risk. This article walks through three stocks from our US Large Cap Value and High Dividend Stocks screener that appear more directly exposed to this rate shift, and...
NYSE:VVX
NYSE:VVXAerospace & Defense

V2X (VVX) Wins Fresh Defense Contracts, Is The Stock Still Undervalued?

V2X (VVX) is back in focus after a series of new U.S. defense contracts, including a logistics integration support deal with the Marine Corps and long term sustainment work for Navy and Air Force aircraft fleets. See our latest analysis for V2X. These contracts and the recent leadership change have arrived during a strong run for V2X, with the share price up 48.76% year to date and a 63.83% three year total shareholder return, indicating momentum that has built over time. If defense logistics...
NasdaqGS:DORM
NasdaqGS:DORMAuto Components

Does Stronger Earnings And ESOP Shelf Registration Change The Bull Case For Dorman Products (DORM)?

Dorman Products recently filed a US$228.49 million shelf registration for 1,709,870 common shares tied to its employee stock ownership plan, while also reporting second-quarter 2026 sales of US$544.60 million and net income of US$87.77 million, both higher than a year earlier. The company’s stronger earnings alongside the completion of a US$137.11 million share repurchase program highlight its active capital management and support for employee ownership. We will now examine how Dorman’s...